Streetbeat News

Products Services

IKNA

Ikena Oncology has announced that it will discontinue the development of its drug candidate IK-930. The company is also evaluating strategic options for its overall development pipeline and the company itself.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:16 pm

DHAI

DIH Holding US, Inc. (NASDAQ:DHAI) has announced a strategic partnership with B-Temia Inc. to drive AI-based innovation in the rehabilitation market. This collaboration aims to enhance the quality of life for individuals needing functional rehabilitation and support.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:12 pm

SGHT

Sight Sciences has published twelve-month results from the SAHARA RCT, showing improved signs and symptoms of dry eye disease for TearCare patients who switched from Restasis.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:11 pm

BMY

PRTA

Prothena will receive $80 million from Bristol Myers Squibb for an exclusive global license to PRX019. A Phase 1 clinical trial is set to begin in 2024.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:08 pm

RSLS

ReShape Lifesciences has received a Notice of Allowance for its U.S. Patent Application 17/572,387 titled 'INTRAGASTRIC DEVICE (FOR TREATING OBESITY)'.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:08 pm

AILE

iLearningEngines and Doblu.ai have announced a partnership to leverage AI for business insights and efficiencies.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:06 pm

LAB

Standard BioTools has acquired the Carterra LSA-XT System, though the financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:05 pm

BTCUSD

DOGEUSD

ETHUSD

SHIBUSD

Cryptocurrency markets are experiencing a slight downturn, with Bitcoin, Ethereum, and Dogecoin all showing losses. Despite this, analysts predict a market bounce. Notable developments include Dogecoin's potential rise and Shiba Inu's strong performance. Futures open interest and liquidations indicate increased leverage and long positions.

Portfolio Pulse from Ivan Crnogatić

May 28, 2024 | 7:51 pm

MRNA

Moderna Inc. (NASDAQ:MRNA) shares are trading lower after a recent surge due to bird flu concerns and predictions of a slight rise in COVID-19 cases. Despite CDC assurances, concerns about bird flu have increased, prompting Moderna and other vaccine manufacturers to test human vaccines against it. Experts also anticipate a small rise in COVID-19 cases due to the new KP.2 variant.

Portfolio Pulse from Vaishali Prayag

May 28, 2024 | 7:36 pm

BNO

USO

Oil prices are trading higher ahead of the upcoming OPEC+ meeting, which could influence future production levels and market dynamics.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 7:13 pm